These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 15562234)

  • 1. Pioglitazone treatment of insulin resistance in a patient with Werner's syndrome.
    Hattori S; Kasai M; Namatame T; Hattori Y; Kasai K
    Diabetes Care; 2004 Dec; 27(12):3021-2. PubMed ID: 15562234
    [No Abstract]   [Full Text] [Related]  

  • 2. [Werner's syndrome].
    Suzuki K; Hattori Y; Kasai K
    Nihon Rinsho; 2006 Sep; Suppl 3():134-7. PubMed ID: 17022517
    [No Abstract]   [Full Text] [Related]  

  • 3. Pioglitazone-reduced insulin resistance in patient with Werner syndrome.
    Imano E; Kanda T; Kawamori R; Kajimoto Y; Yamasaki Y
    Lancet; 1997 Nov; 350(9088):1365. PubMed ID: 9365455
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased insulin responsiveness after CS-045 treatment in diabetes associated with Werner's syndrome.
    Takino H; Okuno S; Uotani S; Yano M; Matsumoto K; Kawasaki E; Takao Y; Yamasaki H; Yamaguchi Y; Akazawa S
    Diabetes Res Clin Pract; 1994 Jul; 24(3):167-72. PubMed ID: 7988348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troglitazone ameliorates insulin resistance in patients with Werner's syndrome.
    Izumino K; Sakamaki H; Ishibashi M; Takino H; Yamasaki H; Yamaguchi Y; Chikuba N; Matsumoto K; Akazawa S; Tokuyama K; Nagataki S
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2391-5. PubMed ID: 9253306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of long-term treatments with testosterone replacement and pioglitazone on glucose and lipid metabolism in male patients with Werner's syndrome.
    Yamamoto H; Kurebayashi S; Kouhara H; Yoshiuchi K; Matsuhisa M; Yamasaki Y; Kasayama S
    Clin Chim Acta; 2007 Apr; 379(1-2):167-70. PubMed ID: 17306780
    [No Abstract]   [Full Text] [Related]  

  • 7. Early amelioration of insulin resistance and reduction of interleukin-6 in Werner syndrome using pioglitazone.
    Honjo S; Yokote K; Fujishiro T; Maezawa Y; Sato S; Koshizaka M; Saito Y
    J Am Geriatr Soc; 2008 Jan; 56(1):173-4. PubMed ID: 18184212
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic improvement and abdominal fat redistribution in Werner syndrome by pioglitazone.
    Yokote K; Honjo S; Kobayashi K; Fujimoto M; Kawamura H; Mori S; Saito Y
    J Am Geriatr Soc; 2004 Sep; 52(9):1582-3. PubMed ID: 15341572
    [No Abstract]   [Full Text] [Related]  

  • 9. Biguanide, but not thiazolidinedione, improved insulin resistance in Werner syndrome.
    Yasuda H; Nagata M; Hara K; Moriyama H; Yokono K
    J Am Geriatr Soc; 2010 Jan; 58(1):181-2. PubMed ID: 20122053
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of pioglitazone on glucose metabolism and luteinizing hormone secretion in women with polycystic ovary syndrome.
    Glintborg D; Hermann AP; Andersen M; Hagen C; Beck-Nielsen H; Veldhuis JD; Henriksen JE
    Fertil Steril; 2006 Aug; 86(2):385-97. PubMed ID: 16782094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of troglitazone, but not pioglitazone, reduces insulin resistance caused by short-term dexamethasone (DXM) treatment by accelerating the metabolism of DXM.
    Morita H; Oki Y; Ito T; Ohishi H; Suzuki S; Nakamura H
    Diabetes Care; 2001 Apr; 24(4):788-9. PubMed ID: 11315852
    [No Abstract]   [Full Text] [Related]  

  • 12. Binding and tyrosine kinase activities of the insulin receptor on Epstein-Barr virus transformed lymphocytes from patients with Werner's syndrome.
    Kakehi T; Kuzuya H; Yoshimasa Y; Yamada K; Okamoto M; Nishimura H; Imura H
    J Gerontol; 1988 Mar; 43(2):M40-5. PubMed ID: 2831266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis.
    Belfort R; Harrison SA; Brown K; Darland C; Finch J; Hardies J; Balas B; Gastaldelli A; Tio F; Pulcini J; Berria R; Ma JZ; Dwivedi S; Havranek R; Fincke C; DeFronzo R; Bannayan GA; Schenker S; Cusi K
    N Engl J Med; 2006 Nov; 355(22):2297-307. PubMed ID: 17135584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance in Werner's syndrome.
    Okamoto M; Okamoto M; Yamada K; Yoshimasa Y; Kosaki A; Kono S; Inoue G; Maeda I; Kubota M; Hayashi T
    Mech Ageing Dev; 1992 Mar; 63(1):11-25. PubMed ID: 1602838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
    Miyazaki Y; DeFronzo RA
    Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct comparison among oral hypoglycemic agents and their association with insulin resistance evaluated by euglycemic hyperinsulinemic clamp: the 60's study.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Gravina A; Mereu R; Palumbo I; D'Angelo A; Cicero AF
    Metabolism; 2009 Aug; 58(8):1059-66. PubMed ID: 19394976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone-induced insulin sensitization improves vascular endothelial function in nondiabetic patients with essential hypertension.
    Horio T; Suzuki M; Takamisawa I; Suzuki K; Hiuge A; Yoshimasa Y; Kawano Y
    Am J Hypertens; 2005 Dec; 18(12 Pt 1):1626-30. PubMed ID: 16364837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes.
    Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Numao T; Fukuda T; Shimada K; Kario K
    Hypertens Res; 2007 Jan; 30(1):23-30. PubMed ID: 17460368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble CD36 and risk markers of insulin resistance and atherosclerosis are elevated in polycystic ovary syndrome and significantly reduced during pioglitazone treatment.
    Glintborg D; Højlund K; Andersen M; Henriksen JE; Beck-Nielsen H; Handberg A
    Diabetes Care; 2008 Feb; 31(2):328-34. PubMed ID: 18000176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pioglitazone effects on blood pressure in patients with metabolic syndrome].
    Takahashi A; Kushiro T
    Nihon Rinsho; 2008 Aug; 66(8):1591-5. PubMed ID: 18700562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.